An Overview of Irritable Bowel Syndrome

An Overview of Irritable Bowel Syndrome is organized by AchieveCE. This course has been approved for a maximum of 2.0 Contact Hours.

Release Date: 06/21/2026
Expiration Date: 06/21/2029

Description:
In the evolving landscape of gastroenterology, healthcare professionals must stay abreast of the latest guidelines and treatment strategies for managing Irritable Bowel Syndrome (IBS). This comprehensive course offers an in-depth exploration of current diagnostic criteria and advanced therapeutic approaches tailored to the diverse manifestations of IBS. Participants will gain insights into the epidemiology and complex pathophysiology of IBS, understand its common comorbid conditions, and learn to navigate the intricacies of the brain-gut axis. The course underscores the significance of a holistic diagnostic workup, including psychosocial assessments and the identification of alarm features, and provides evidence-based guidance on lifestyle modifications, dietary interventions, and pharmacotherapy. With a focus on enhancing the therapeutic relationship and adherence to treatment, this training equips healthcare professionals with the tools to improve patient outcomes and quality of life. This essential knowledge is pivotal for those in clinical practice, enabling them to address the multifaceted challenges of IBS with confidence and precision.

What you will learn:
At the conclusion of this course, participants will be able to:

• Describe the conceptual and diagnostic advancements in IBS.
• Identify the clinical presentations and comorbid conditions associated with IBS.
• Conduct a comprehensive diagnostic workup for IBS.
• Design individualized treatment plans for IBS based on predominant symptoms.
• Identify strategies to enhance patient adherence and outcomes in IBS management.

Course Features

• Instant certificates
• All required courses
• Instant reporting to CE Broker
• 7-day live chat & phone support
• Auto reporting to CPE Monitor
• Unlimited course attempts

Course content

• Introduction
• Conceptual and Diagnostic Advances
• Epidemiology
• Common Comorbid Conditions
• Natural History
• Common Comorbid Conditions
• Contributing Factors
• Etiology, Pathogenesis, And Pathophysiology
• Psychological Factors and Psychiatric Disorders
• Factors Influencing Functional GI Disorders (FGIDs)
• Brain-Gut Axis and Processing
• Altered Pain Perception in Patients With IBS
• Altered Brain Network Function
• Altered Brain Structure
• Clinical Presentation and Diagnostic Workup
• Clinical Presentation
• Diagnostic Criteria and Measurement Scales
• Diagnostic Criteria for IBS Subtypes
• Clinical Evaluation and Diagnostic Workup
• Clinical History
• Physical Examination
• Differential Diagnosis
• Laboratory Studies
• Alarm Features
• Psychosocial Assessment
• Changes in Symptom Severity, Frequency, or Treatment Response
• Treatment
• The Therapeutic Relationship and Treatment Adherence
• Steps to Enhance the Therapeutic Relationship
• Steps to Enhance Therapy Adherence
• Lifestyle Modification
• Dietary Interventions
• Antidepressant Medications
• Choice of Agent
• Augmentation of Therapy
• Diarrhea-Predominant IBS
• Mu Opioid Receptor Agonists
• Bile Acid Binders (Sequestrants)
• Nonabsorbable Antibiotics
• 5-HT3 Receptor Antagonists
• Eluxadoline
• Mast Cell Stabilizers
• Muscarinic Type 3 Receptor Antagonists
• Glutamine
• Summary
• Constipation-Predominant IBS
• Laxatives
• Secretagogues
• 5-HT4 Receptor Agonists
• Summary
• Abdominal Pain-Predominant IBS
• Antispasmodics (Spasmolytics)
• Peppermint Oil
• Linaclotide
• Antidepressants
• Pregabalin
• Histamine H1 Receptor Antagonists
• Fecal Microbial Transplantation
• Specialist Referral
• Conclusion